Clinical Trial Update: Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating Gliomas [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial evaluates the feasibility of hyperpolarized 13C-pyruvate metabolic MRI for imaging infiltrating gliomas. The sponsor is University o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Glioma | Phase 1 | Status: RECRUITING